AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. AstraZeneca is committed to pushing the boundaries of science to deliver life-changing medicines.
45000 / day
50000 / day
4.2 pages per visit
Domain Rating
Domain Authority
Citation Level
English, etc
AstraZeneca is at the forefront of developing innovative medicines that address some of the world's most serious diseases.
With operations in over 100 countries, AstraZeneca has a significant global presence, ensuring its medicines reach patients worldwide.
The company invests heavily in R&D to discover and develop new treatments for a wide range of diseases.
AstraZeneca is committed to sustainability, aiming to deliver its medicines in a way that is environmentally responsible.
AstraZeneca offers comprehensive support programs to help patients access and adhere to their prescribed treatments.
The company leverages digital health technologies to improve patient outcomes and healthcare delivery.
AstraZeneca collaborates with academic institutions, biotech companies, and other partners to accelerate the development of new medicines.
The company conducts extensive clinical trials to ensure the safety and efficacy of its medicines.
AstraZeneca is dedicated to making a positive impact on society through its corporate responsibility initiatives.
The company invests in the development of its employees, fostering a culture of innovation and excellence.
Cambridge, United Kingdom
Pascal Soriot
Approximately 76,100 globally
$26.6 billion (2020)
Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology
AstraZeneca developed a COVID-19 vaccine in collaboration with the University of Oxford, which has been authorized for emergency use in many countries.
AstraZeneca aims to be carbon negative across its entire value chain by 2030.
The company has established innovation hubs in key locations around the world to foster collaboration and accelerate the development of new treatments.
Security headers report is a very important part of user data protection. Learn more about http headers for astrazeneca.com